loadpatents
name:-0.038378953933716
name:-0.042212009429932
name:-0.0025708675384521
Washburn; William N. Patent Filings

Washburn; William N.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Washburn; William N..The latest application filed is for "pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists".

Company Profile
3.40.29
  • Washburn; William N. - Titusville NJ
  • - Titusville NJ US
  • Washburn; William N. - LaJolla CA
  • Washburn; William N. - Ionia NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
Grant 9,586,900 - Ahmad , et al. March 7, 2
2017-03-07
Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
Grant 9,499,482 - Washburn , et al. November 22, 2
2016-11-22
Pyrrolone Or Pyrrolidinone Melanin Concentrating Hormone Receptor-1 Antagonists
App 20150218092 - Washburn; William N. ;   et al.
2015-08-06
Pyrrolone Or Pyrrolidinone Melanin Concentrating Hormone Receptor-1 Antagonists
App 20150218093 - Ahmad; Saleem ;   et al.
2015-08-06
Bicyclic nitrogen containing heteroaryl TGR5 receptor modulators
Grant 9,062,028 - Robl , et al. June 23, 2
2015-06-23
Azolotriazinone melanin concentrating hormone receptor-1 antagonists
Grant 8,754,211 - Devasthale , et al. June 17, 2
2014-06-17
Novel Bicyclic Nitrogen Containing Heteroaryl Tgr5 Receptor Modulators
App 20140080788 - Robl; Jeffrey A. ;   et al.
2014-03-20
Azolotriazinone Melanin Concentrating Hormone Receptor-1 Antagonists
App 20140031337 - Devasthale; Pratik ;   et al.
2014-01-30
Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them
Grant 08618115 -
2013-12-31
Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them
Grant 8,618,115 - Washburn , et al. December 31, 2
2013-12-31
Azolotriazinone melanin concentrating hormone receptor-1 antagonists
Grant 8,580,959 - Devasthale , et al. November 12, 2
2013-11-12
Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
Grant 8,563,583 - Ahmad , et al. October 22, 2
2013-10-22
Azolopyrrolone melanin concentrating hormone receptor-1 antagonists
Grant 8,415,386 - Devasthale , et al. April 9, 2
2013-04-09
Pyrrolone melanin concentrating hormone receptor-1 antagonists
Grant 8,344,160 - Zhao , et al. January 1, 2
2013-01-01
Methods for treating obesity employing an SGLT2 inhibitor
Grant 8,088,743 - Washburn , et al. January 3, 2
2012-01-03
Pyridone Analogs Useful As Melanin Concentrating Hormone Receptor-1 Antagonists
App 20110319449 - Ahmad; Saleem ;   et al.
2011-12-29
Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods
Grant 8,067,420 - Stein , et al. November 29, 2
2011-11-29
Azolotriazinone Melanin Concentrating Hormone Receptor-1 Antagonists
App 20110218185 - Devasthale; Pratik ;   et al.
2011-09-08
Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods
Grant 8,012,984 - Stein , et al. September 6, 2
2011-09-06
Pyrrolone Melanin Concentrating Hormone Receptor-1 Antagonists
App 20110195986 - Zhao; Guohua ;   et al.
2011-08-11
Substituted thieno[3,2-D]pyrimidines as melanin concentrating hormone receptor-1 antagonists
Grant 7,989,433 - Washburn , et al. August 2, 2
2011-08-02
Non-basic melanin concentrating hormone receptor-1 antagonists
Grant 7,973,159 - Washburn , et al. July 5, 2
2011-07-05
Substituted Pyrazinone Melanin Concentrating Hormone Receptor-1 Antagonists And Methods
App 20110144060 - Stein; Philip D. ;   et al.
2011-06-16
Non-basic Melanin Concentrating Hormone Receptor-1 Antagonists
App 20110034375 - Washburn; William N. ;   et al.
2011-02-10
Non-basic Melanin Concentrating Hormone Receptor-1 Antagonists And Methods
App 20110003759 - Stein; Philip D. ;   et al.
2011-01-06
Non-basic melanin concentrating hormone receptor-1 antagonists
Grant 7,851,622 - Washburn , et al. December 14, 2
2010-12-14
Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists
Grant 7,745,447 - Washburn , et al. June 29, 2
2010-06-29
Hydroxy Substituted Thieno Pyrimidinones As Melanin Concentrating Hormone Receptor-1 Antagonists
App 20090298794 - Washburn; William N. ;   et al.
2009-12-03
Stable Oral Pharmaceutical Composition Containing Thyroid Hormone Receptor Agonists
App 20090220598 - Garg; Neeraj ;   et al.
2009-09-03
Non-basic Melanin Concentrating Hormone Receptor-1 Antagonists And Methods
App 20090011994 - Stein; Philip D. ;   et al.
2009-01-08
Non-basic Melanin Concentrating Hormone Receptor-1 Antagonists
App 20080269110 - Washburn; William N. ;   et al.
2008-10-30
Methods for Treating Obesity Employing an SGLT2 Inhibitor and Compositions Thereof
App 20080234367 - Washburn; William N. ;   et al.
2008-09-25
2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
Grant 7,365,061 - Sher , et al. April 29, 2
2008-04-29
Substituted anilide ligands for the thyroid receptor
Grant 7,342,127 - Washburn , et al. March 11, 2
2008-03-11
2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors
Grant 7,223,786 - Meng , et al. May 29, 2
2007-05-29
Non-basic melanin concentrating hormone receptor-1 antagonists
App 20070093508 - Ahmad; Saleem ;   et al.
2007-04-26
Non-basic melanin concentrating hormone receptor-1 antagonists
App 20070093509 - Washburn; William N. ;   et al.
2007-04-26
2-Amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
App 20060111338 - Sher; Philip M. ;   et al.
2006-05-25
2-Aminonaphthalene derivatives and related glycogen phosphorylase inhibitors
App 20060111415 - Meng; Wei ;   et al.
2006-05-25
2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
App 20060111413 - Sher; Philip M. ;   et al.
2006-05-25
C-aryl glucoside SGLT2 inhibitors and method
Grant 6,936,590 - Washburn , et al. August 30, 2
2005-08-30
Substituted anilide ligands for the thyroid receptor
App 20040180940 - Washburn, William N. ;   et al.
2004-09-16
Cycloalkyl containing anilide ligands for the thyroid receptor
App 20040176425 - Washburn, William N. ;   et al.
2004-09-09
O-aryl glucoside SGLT2 inhibitors and method
Grant 6,683,056 - Washburn , et al. January 27, 2
2004-01-27
C-aryl glucoside SGLT2 inhibitors and method
App 20030114390 - Washburn, William N. ;   et al.
2003-06-19
O-pyrazole glucoside SGLT2 inhibitors and method of use
App 20030087843 - Washburn, William N.
2003-05-08
O-glucosylated benzamide SGLT2 inhibitors and method
Grant 6,555,519 - Washburn April 29, 2
2003-04-29
C-aryl glucoside SGLT2 inhibitors and method
Grant 6,515,117 - Ellsworth , et al. February 4, 2
2003-02-04
C-aryl glucoside SGLT2 inhibitors and method
App 20020137903 - Ellsworth, Bruce ;   et al.
2002-09-26
2-hydroxy-3--(4-hydroxy-3-sulfonamidophenyl)--propylamines useful as beta 3 adrenergic agonists
Grant 6,436,914 - Sher , et al. August 20, 2
2002-08-20
O-aryl glucoside SGLT2 inhibitors and method
App 20020111315 - Washburn, William N. ;   et al.
2002-08-15
C-aryl glucoside SGLT2 inhibitors and method
Grant 6,414,126 - Ellsworth , et al. July 2, 2
2002-07-02
O-glucosylated benzamide SGLT2 inhibitors and method
App 20020052326 - Washburn, William N.
2002-05-02
2-hydroxy-3 - (4-hydroxy-3-sulfonamidophenyl) - propylamines useful as beta 3 adrenergic agonists
App 20020026065 - Sher, Philip M. ;   et al.
2002-02-28
Catecholamine surrogates useful as .beta..sub.3 agonists
Grant 5,776,983 - Washburn , et al. July 7, 1
1998-07-07
Catecholamine surrogates useful as .beta..sub.3 agonists
Grant 5,770,615 - Cheng , et al. June 23, 1
1998-06-23
Aryloxypropanolamine beta 3 adrenergic agonists
Grant 5,723,489 - Sher , et al. March 3, 1
1998-03-03
Hydrolytic enzyme inhibitors/inactivators and methods for using same
Grant 5,567,597 - Dennis , et al. October 22, 1
1996-10-22
Aryloxypropanolamine .beta. 3 adrenergic agonists
Grant 5,541,204 - Sher , et al. July 30, 1
1996-07-30
Hydrolytic enzyme inhibitors/inactivators and methods for using same
Grant 5,308,766 - Dennis , et al. May 3, 1
1994-05-03
3,4-disubstituted phenols-immunomodulating agents
Grant 5,258,407 - Washburn , et al. * November 2, 1
1993-11-02
Photographic element and process comprising a blocked photographically useful compound
Grant 5,019,492 - Buchanan , et al. May 28, 1
1991-05-28
Color-forming couplers and their use in the analytical determination of hydrogen peroxide or other analytes
Grant 4,672,029 - Washburn , et al. June 9, 1
1987-06-09
Colorless ligand-releasing monomers and polymers and their use to provide dyes with metal ions
Grant 4,557,998 - Washburn , et al. December 10, 1
1985-12-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed